Pacific Diabetes Technologies

Website

Pacific Diabetes Technologies, Inc.

5 Investors
Medical Device Manufacturing
PORTLAND, OR

Pacific Diabetes Technologies, Inc. (PDT) is a pioneering company focused on developing advanced diabetes management devices aimed at streamlining treatment for individuals with insulin-dependent diabetes. Their innovative approach integrates multiple functions into a single device to enhance user experience and improve health outcomes.

Products & Team

SynerG™ Device

Diabetes Management DeviceSeed

The SynerG™ device is a revolutionary combination of continuous glucose monitoring and insulin delivery systems, designed to be worn as a single unit. This innovative device eliminates the necessity for separate devices, making diabetes management more efficient and less intrusive.

Value Proposition

The SynerG™ device provides a comprehensive solution to the complications of managing insulin-dependent diabetes by reducing the burden on patients through simplified monitoring and insulin administration.

Pain Points

Patients often face challenges related to cumbersome diabetes management protocols, complications from the need to use multiple devices, and the anxiety of frequent skin punctures required for monitoring and insulin delivery.

Combines CGM and insulin delivery functionsSingle-port design for ease of useMinimizes the need for multiple insertion sitesUser-friendly interface for real-time data tracking
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
PORTLAND, OR
Primary headquarters

Funding History

Total Raised:
$2.1M
E

Equity Offering

March 2025
$5.0M
Target
Progress
41%
Raised
$2.1M
Target
$5.0M
#000183547625000001